Clarification of the Scope for PAR-13-095 "Differentiation and Integration of Stem Cells (Embryonic and Induced-Pluripotent) into Developing or Damaged Tissues (R21)"

Notice Number: NOT-HD-13-011

Release Date: August 12, 2013

PAR-13-095

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

The purpose of this Notice is to clarify that the scope of the funding opportunity announcement (FOA) PAR-13-095, as described in the announcement, remains unchanged, but is restricted to research on the following developmental and pathological conditions:

• Research on developmental disorders, including structural birth defects and intellectual disabilities
• Research on the pathophysiology and management of chronically injured nervous and musculoskeletal systems (including stroke, traumatic brain injury, spinal cord injury, and orthopedic conditions); repair and recovery of motor and cognitive function; functional plasticity, adaptation, and windows of opportunity for rehabilitative interventions
• Research on reproductive pathophysiology, development of more effective strategies for management, and prevention of conditions that compromise fertility.

Although applicants are free to submit a stem cell application to the parent NIH R21 announcement, those responding to PAR-13-095 must make clear the applications address developmental disorders, medical rehabilitation or reproductive pathophysiology.

Other aspects of these FOAs remain unchanged.

Please direct all inquiries to:

Mahua Mukhopadhyay, Ph. D.
Developmental Biology and Structural Variation Branch
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Telephone: (301) 435-6886
Fax: (301) 480-0303
Email: [email protected]